Ophthalmological abnormalities in children with congenital disorders of glycosylation type I - PubMed (original) (raw)
Ophthalmological abnormalities in children with congenital disorders of glycosylation type I
E Morava et al. Br J Ophthalmol. 2009 Mar.
Abstract
Background: Children with congenital disorders of glycosylation (CDG) type Ia frequently present with ocular involvement and visual loss. Little is known, however, about the occurrence of ophthalmological abnormalities in other subtypes of CDG syndrome.
Methods: We evaluated 45 children sequentially diagnosed with CDG type I for the presence of ocular abnormalities at the time of the diagnosis and during follow-up. We compared the various ophthalmic findings in the different CDG subgroups.
Results: Of the 45 patients, 22 had CDG type Ia, nine had CDG type Ic and 14 had a so-far undiagnosed biochemical background (CDG type Ix). We found ocular anomalies in 28 of the 45 children. Three had unique findings, including congenital cataract, retinal coloboma and glaucoma. A few CDG type Ia patients showed a sequential occurrence of symptoms, including retinitis pigmentosa or cataract.
Conclusions: Ophthalmic findings are frequent in CDG syndrome involving both the anterior and posterior segment of the eye. The disorder might lead to abnormal development of the lens or the retina, cause diminished vision, alter ocular motility and intraocular pressure. We suggest routine screening and follow-up for ophthalmological anomalies in all children diagnosed with CDG syndrome to provide early treatment and adequate counselling.
Similar articles
- Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia).
Krasnewich D, O'Brien K, Sparks S. Krasnewich D, et al. Am J Med Genet C Semin Med Genet. 2007 Aug 15;145C(3):302-6. doi: 10.1002/ajmg.c.30143. Am J Med Genet C Semin Med Genet. 2007. PMID: 17639595 Review. - Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia.
Miossec-Chauvet E, Mikaeloff Y, Heron D, Merzoug V, Cormier-Daire V, de Lonlay P, Matthijs G, Van Hulle C, Ponsot G, Seta N. Miossec-Chauvet E, et al. Neuropediatrics. 2003 Feb;34(1):1-6. doi: 10.1055/s-2003-38614. Neuropediatrics. 2003. PMID: 12690561 - Congenital disorders of glycosylation: a rare cause of nephrotic syndrome.
Sinha MD, Horsfield C, Komaromy D, Booth CJ, Champion MP. Sinha MD, et al. Nephrol Dial Transplant. 2009 Aug;24(8):2591-4. doi: 10.1093/ndt/gfp226. Epub 2009 May 27. Nephrol Dial Transplant. 2009. PMID: 19474279 - CDG type Ia and congenital cytomegalovirus infection: two coexisting conditions.
Jamroz E, Adamek D, Paprocka J, Adamowicz M, Marszał E, Wevers RA. Jamroz E, et al. J Child Neurol. 2009 Jan;24(1):13-8. doi: 10.1177/0883073808321041. J Child Neurol. 2009. PMID: 19168813 - The skeletal manifestations of the congenital disorders of glycosylation.
Coman D, Irving M, Kannu P, Jaeken J, Savarirayan R. Coman D, et al. Clin Genet. 2008 Jun;73(6):507-15. doi: 10.1111/j.1399-0004.2008.01015.x. Epub 2008 May 6. Clin Genet. 2008. PMID: 18462449 Review.
Cited by
- Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.
Bremova-Ertl T, Hofmann J, Stucki J, Vossenkaul A, Gautschi M. Bremova-Ertl T, et al. Cells. 2023 Sep 19;12(18):2314. doi: 10.3390/cells12182314. Cells. 2023. PMID: 37759536 Free PMC article. Review. - Rare variant analyses across multiethnic cohorts identify novel genes for refractive error.
Musolf AM, Haarman AEG, Luben RN, Ong JS, Patasova K, Trapero RH, Marsh J, Jain I, Jain R, Wang PZ, Lewis DD, Tedja MS, Iglesias AI, Li H, Cowan CS; Consortium for Refractive Error and Myopia (CREAM); Biino G, Klein AP, Duggal P, Mackey DA, Hayward C, Haller T, Metspalu A, Wedenoja J, Pärssinen O, Cheng CY, Saw SM, Stambolian D, Hysi PG, Khawaja AP, Vitart V, Hammond CJ, van Duijn CM, Verhoeven VJM, Klaver CCW, Bailey-Wilson JE. Musolf AM, et al. Commun Biol. 2023 Jan 3;6(1):6. doi: 10.1038/s42003-022-04323-7. Commun Biol. 2023. PMID: 36596879 Free PMC article. - Acetazolamide treatment in late onset CDG type 1 due to biallelic pathogenic DHDDS variants.
Mousa J, Veres L, Mohamed A, De Graef D, Morava E. Mousa J, et al. Mol Genet Metab Rep. 2022 Jul 25;32:100901. doi: 10.1016/j.ymgmr.2022.100901. eCollection 2022 Sep. Mol Genet Metab Rep. 2022. PMID: 36046393 Free PMC article. - Case Report: Multiple Retinal Astrocytic Hamartomas in Congenital Disorder of Glycosylation-Ia.
Midena G, Pilotto E. Midena G, et al. Front Med (Lausanne). 2022 Feb 14;9:697030. doi: 10.3389/fmed.2022.697030. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35237617 Free PMC article. - Clinical and biochemical footprints of inherited metabolic disorders. VII. Ocular phenotypes.
Garanto A, Ferreira CR, Boon CJF, van Karnebeek CDM, Blau N. Garanto A, et al. Mol Genet Metab. 2022 Apr;135(4):311-319. doi: 10.1016/j.ymgme.2022.02.002. Epub 2022 Feb 15. Mol Genet Metab. 2022. PMID: 35227579 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical